Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.32 |
| ▸ | PDE1A | P54750 | 1/20 | 0.31 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.31 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.31 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24156068 | 0.87 | NOTUM (0.43) | ELANEMTNR1AMTNR1BALDH1A1NPC1 | |
| SCHEMBL6508278 | 0.85 | PDE4C (0.39) | ELANEMTNR1AMTNR1BMAPTALDH1A1 | |
| SCHEMBL17231489 | 0.85 | ALDH1A1 (0.38) | ELANEMTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL17231504 | 0.84 | ALDH1A1 (0.37) | ELANEMTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL23641593 | 0.84 | MAPK14 (0.41) | ELANEMTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL11110191 | 0.82 | MTNR1A (0.35) | ELANEMTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL17691868 | 0.82 | HPRT1 (0.45) | MAPTALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL14280235 | 0.81 | TDP1 (0.41) | ELANEMTNR1AMTNR1BACLYMAPT | |
| SCHEMBL17691847 | 0.80 | ALDH1A1 (0.38) | ELANEMTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL6049478 | 0.78 | MTNR1A (0.33) | ELANEMTNR1AMTNR1BHTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050159596-A1 | Cyclic compounds and their use as complex ligands | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-21 | — | — | US | disclosed |
| EP-1476447-A1 | CYCLIC COMPOUNDS AND THEIR USE AS COMPLEX LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-17 | — | — | EP | disclosed |
| WO-2003068779-A1 | CYCLIC COMPOUNDS AND THEIR USE AS COMPLEX LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159596-A1 | Cyclic compounds and their use as complex ligands | CXCR4, CXCR3, CX3CR1 | ELANE 596/4885MTNR1A 2319/4885MTNR1B 2269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.